Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MDVL

MedAvail (MDVL) Stock Price, News & Analysis

MedAvail logo

About MedAvail Stock (NASDAQ:MDVL)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
$1.80
$5.95
52-Week Range
N/A
Volume
245,100 shs
Average Volume
261,432 shs
Market Capitalization
$2.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, and kiosk solutions in the United States and Canada. It offers a pharmacy technology solution, including the MedAvail MedCenter, which enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio-visual connection to a live pharmacist enabling prescription drug dispensing to occur directly to a patient with real-time supervision by a pharmacist. The company is headquartered in Phoenix, Arizona. On February 2, 2024, MedAvail Holdings, Inc along with its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.

Remove Ads
Receive MDVL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MedAvail and its competitors with MarketBeat's FREE daily newsletter.

MDVL Stock News Headlines

Delhi Bank Corp DWNX
Huge Elon-backed AI rollout begins – buy these nine stocks
If you suspect Elon Musk has an ulterior motive for coming to Washington, D.C.... You're 100% correct. He didn't just join the government to cut federal spending... He's here to LAUNCH the most ambitious innovation of his career.
See More Headlines

MDVL Stock Analysis - Frequently Asked Questions

MedAvail Holdings, Inc. (NASDAQ:MDVL) issued its quarterly earnings results on Monday, November, 8th. The company reported ($0.34) earnings per share for the quarter, missing analysts' consensus estimates of ($0.32) by $0.02. The company earned $5.79 million during the quarter. MedAvail had a negative trailing twelve-month return on equity of 218.10% and a negative net margin of 192.97%.

Based on aggregate information from My MarketBeat watchlists, some other companies that MedAvail investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), CrowdStrike (CRWD), Adobe (ADBE), Braze (BRZE) and e.l.f. Beauty (ELF).

Company Calendar

Last Earnings
11/08/2021
Today
4/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Drug stores & proprietary stores
Sub-Industry
N/A
Current Symbol
NASDAQ:MDVL
Employees
279
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-47,620,000.00
Net Margins
-192.97%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$43.33 million
Price / Cash Flow
N/A
Book Value
$13.01 per share
Price / Book
N/A

Miscellaneous

Free Float
1,590,000
Market Cap
$2.91 million
Optionable
No Data
Beta
0.76
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:MDVL) was last updated on 4/8/2025 by MarketBeat.com Staff
From Our Partners